EVG — Evgen Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- £3.31m
- -£0.42m
- £0.44m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.03 | 4.13 | 11.6 | 9.03 | 5 |
Net Total Receivables | 0.589 | 0.531 | 0.652 | 0.483 | 1.02 |
Prepaid Expenses | |||||
Total Current Assets | 2.66 | 4.77 | 12.3 | 9.58 | 6.13 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.006 | 0.002 | 0.005 | 0.005 | 0.003 |
Net Intangible Assets | |||||
Total Assets | 2.76 | 4.86 | 12.4 | 9.64 | 6.17 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.688 | 0.653 | 0.607 | 0.411 | 0.833 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.688 | 0.653 | 0.607 | 0.411 | 0.833 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2.08 | 4.2 | 11.8 | 9.23 | 5.34 |
Total Liabilities & Shareholders' Equity | 2.76 | 4.86 | 12.4 | 9.64 | 6.17 |
Total Common Shares Outstanding |